Suppression of Autoimmunity and Renal Disease in Pristane‐Induced Lupus by Myeloperoxidase

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|7|1868-1880

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.7, 2015-07, pp. : 1868-1880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane‐induced lupus nephritis in mice

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 407-416

John Wiley & Sons Inc

Access to resources Recommend Favorite

An adipokine marker in lupus nephritis

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 179, Iss. 3, 2015-03 ,pp. : 435-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Levels of BAFF and APRIL in Myeloperoxidase Anti-Neutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis: Association with Disease Activity

By  

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-02 ,pp. : c339-c345

Karger

Access to resources Recommend Favorite

Editorial: Autoimmunity to Vimentin and Lupus Nephritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3251-3254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rosuvastatin-Induced Arrest in Progression of Renal Disease

By  

Cardiology, Vol. 102, Iss. 1, 2004-04 ,pp. : 52-60

Karger

Access to resources Recommend Favorite